Activities: The Cancer Foundation's "Metastatic Breast Cancer" webinar, managed by Healthy Blossom, featured Dr. Dodagoudar's opening remarks. Dr. Gupta discussed Low HER2 Breast Cancer, Dr. Dubey explored HER2-negative early breast cancer, and Dr. Bajpai presented Kryxana. Dr. Singhal discussed strategies for HR+/HER2- patients, Dr. Babbar highlighted Atezolizumab in mTNBC, and Dr. Vidushi covered flexible approaches for HER2-positive breast cancer. Dr. Sardana explored immunotherapy in TNBC, with Dr. Dodagoudar providing closing remarks.
Aim: The Cancer Foundation's "Metastatic Breast Cancer" webinar, managed by Healthy Blossom, aimed to advance understanding and discuss treatment strategies for various breast cancer types. Leading medical experts presented insights, from exploring HER2 and HR status to discussing innovative treatments, ultimately fostering knowledge exchange and help in breast cancer care.
Impact: The webinar deepened breast cancer understanding, exploring clinical strategies, innovative treatments like Kryxana and Atezolizumab, and discussing future paradigms.
Knowledge Advancement: The webinar facilitated a deeper understanding of breast cancer by delving into topics such as Low HER2 and HER2-negative early breast cancer, providing participants with the latest insights.
Clinical Strategy Exploration: Experts discussed strategic approaches for treating specific breast cancer types, including HR-positive/HER2- negative patients with PIK3CA mutation and those with metastatic triple-negative breast cancer (mTNBC).
Innovative Treatment Insights: Sessions on Kryxana and Atezolizumab shed light on innovative treatments, bridging the gap between randomized controlled trials (RCT) and real- world evidence (RWE).
Future Treatment Paradigms: The discussion on flexible treatment strategies for HER2- positive breast cancer and the integration of immunotherapy into TNBC treatment explored future paradigms in breast cancer care.
Newsletter
